CI & Patent News 27/10/2010


1) Abbott Sues Anchen on Paricalcitol Capsules 1 mcg, 2 mcg, and 4 mcg. Patent in suit US 5,587,497 which expires on Jun 24, 2014 in US assigned to Wisconsin Alumni Research Foundation (Complaint) (Bloomberg)

2) Low cost HIV/AIDS drugs to be available in India by Oct-end (BS)
Darunavir and raltegravir are going to be marketed at low cost in India. As per this news article, two indian drug companies will partner in this program. Emcure is one of the company responsible for manufacturing of darunavir

3) Salix drug approval date pushed out (rifaximin 550 MG) (Yahoo finance)

4) Watson Confirms Crestor(R) Patent Challenge (rosuvastatin) (Press release)

5) Glaxo to pay $750 mn in adulterated drugs case (Live mint)
The drugs — the anti-nausea medicine Kytril, skin ointment Bactroban, anti-depressant Paxil CR and diabetes drug Avandamet — were made at the plant between 2001 and 2005.

6) Astellas Obtained Approval for Vesicare OD in Japan (solifenacin) (Press release)

7) Biocon announced strategic foreign direct investment in malaysia to establish biomanufacturing and R&D facility in Bio-XCell in collaboration with Malaysian biotech corporation (Biotechcorp)

Advertisements

About Guna

Interested to learn things around me
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s